|
CARBON
NANOTUBES FOR TARGETED DRUG DELIVERY
Raman analysis and mapping can be used to rapidly probe an oxidized CNTs sample, extracting information on the presence of acidic groups produced by oxidative treatments usually performed to allow both a better dispersion in solution and the further attachment of biomolecules for drug delivery applications. The Raman signal of CNTs can be exploited to identify their presence inside the cellular membrane during in vitro tests, and to study their biodistribution after in vivo tests. Starting
from the fundamental paper by Ijima in 1991 [Iijima S. Helical microtubules
of graphitic carbon. Nature, 1991, 354, 56-8], carbon nanotubes, both
single and multiwalled ones, have received an ever increasing scientific
and industrial interest due to their exceptional physical and chemical
properties, and have been considered and applied in a growing number
of different fields from electronics to photonics. In particular, their
possible use in the field of biomedicine was recently suggested and
partly demonstrated, turning on a renewed interest and enthusiasm, and
prompting the scientific community to a powerful interdisciplinary approach.
Accordingly, after THA solution mixing with oxidized SWCNTs, almost complete decolourization of the supernatant is observed (figure 2). Therefore, the concentration of COOH groups of an oxidized CNT sample can be determined by measuring the fluorescence emission intensity decrease of the initial dye solution, and subtracting the amount due to unspecific interaction (evaluated on the corresponding non-oxidized CNT sample). Figure 2. Fluorescence emission spectra (left) on raw (p-MW1+THA) and oxidized (f-MW1+THA) THA treated carbon nanotubes. This figure shows that fluorescence intensity decreases after oxidation due to THA interaction with oxidized nanotubes. On the rigth, the difference in fluorescence emission after mixing THA stock solution and oxidized CNTs (f-MW1) or pristine CNTs (p-MW1).
As we
have demonstrated in [2] the presence of the labelling molecules in
the THA treated CNT sample can be also read out by exploiting their
Raman signature [2]. Figure 3 shows the Raman spectrum obtained by using
a Dispersive Raman Spectroscope (DXR Raman spectroscope Thermo Fisher
Scientific, excitation laser 532 nm, laser power 2mW and aperture 50
m pinhole) on a liquid THA sample. It clearly shows a characteristic
peak at about 474 cm-1, whose intensity is related to the number of
molecules present in the analyzed sample.
It is possible to directly use the Raman signal of the THA labelling molecule for the COOH groups determination. We explored the possibility to use our labelling approach to study CNT sample homogeneity and the oxidation treatment efficiency. Figure 4 presents two spectra obtained on different area of a powder sample containing THA treated oxidized SWCNTs, and showing the presence of some of the typical bands ascribed to carbon nanotubes (RBM, D, G, M, G' bands).
Two spectral features can be chosen to discriminate between oxidized and non-oxidized CNTs. The first one is the intensity of the peak located at 475 cm-1, which is associated to the presence of THA molecules (spectrum A). The second one is the intensity of the M band located at about 1723 cm-1, identifying the presence of almost bare pristine SWCNTs (spectrum B). These two peaks can be used as contrast parameters to visualize the Raman (i.e. chemical) map of the sample. The two opposite visualizations of the same map obtained by using the selected THA and M peaks as contrast parameters are presented in figure 5. In both cases a colour going from blue to red indicates increasing intensity of the peak chosen as contrast parameter. The almost perfect complementarity of the maps is evident, definitely indicating the stable and selective bonding of THA with oxidized carbon nanotubes.
As a first step in drug delivery applications, COOH groups produced by the oxidative treatment can be used to covalently functionalize SWCNTs with PEG molecules to enhance their solubility [3], see figure 6.
Raman mapping can be also used in in vitro tests to study carbon nanotubes citotoxicity and their interaction and accumulation inside endothelial cells (HUVE cells). Our results 4 demonstrate that SWCNTs are highly biocompatible and not toxic (studies achieved on a specific SWCNT concentration range) and preferentially accumulate on lysosome inside endothelial cells (figure 7). Figure 7. Raman spectroscopy of single HUVE cells in culture. (A) HUVE cell treated with oxidized SWCNTs. (B) The Raman spectra (solid black line) of a point within the SWCNT-treated HUVE cell shown in (A). The dashed line is a spectra from a point outside the cell. The blue line is the difference between the two spectra. The differential curve was essentially superimposable on the spectra obtained from pure oxidized SWCNTs. (C) A "chemical map" generated from Raman spectra from a series of points within the cell shown in (A), with the blue to red gradient indicating increasing G-band intensity. (D) Superposition of the topographic image of the HUVE cell in (A) with the Raman "chemical map", showing the localization of the SWCNTs to the areas confined by the cell. We then performed in vivo tests on chemically oxidized carbon nanotubes. Preliminary results obtained by Raman spectroscopy investigation of tissue distribution after intravenous injection revealed SWCNT accumulation within the liver and, to a lesser extent, in the spleen (figure 8). Figure 8. Preliminary results obtained by -Raman spectroscopy investigation of tissue distribution after intravenous injection. The black and red specta were obtained, respectively, on liver and spleen samples at different laser excitation powers. The green spectrum is obtained on the oxidized SWCNTs before injection and is reported as a reference. "WHO'S WHO" OF THE PROJECT
[2] V. Mussi, C. Biale, S. Visentin, N. Barbero, M. Rocchia, U. Valbusa, "Raman analysis and mapping for the determination of acidic sites on oxidized single walled carbon nanotubes", accepted for publication on Carbon DOI information: 10.1016/j.carbon.2010.05.032 [3] C. Biale, V. Mussi, U. Valbusa, S. Visentin, G. Viscardi, N. Barbero, N. Pedemonte, L. Galietta, "Carbon nanotubes for targeted drug delivery", Nanotecnology, 2009, Proceedings of IEEE-NANO 2009, 9th IEEE Conference, Publication Year: 2009, Pages: 644 - 646. [4] A.
Albini, V. Mussi, A. Parodi, A. Ventura, E. Principi, S. Tegami, M.
Rocchia, E. Francheschi, I. Sogno, R. Cammarota, G. Finzi, F. Sessa,
D. McClain Noonan, U. Valbusa, "Interactions of single wall carbon
nanotubes with endothelial cells", Nanomedicine: Nanotechnology,
Biology and Medicine, 6 (2010) 277-288.
|
|
|